title: Curcumin induces osteosarcoma MG63 cells apoptosis via ROS/Cyto-C/Caspase-3 pathway.
abstract: The antitumor effects of curcumin have attracted widespread attention worldwide. One of its major functions is to induce the apoptosis of tumor cells, but the antitumor mechanism is currently unclear. In the present study, we found that cell mortality and curcumin concentration were dose dependent. Curcumin of low concentrations (10 μΜ) could reduce the level of reactive oxygen species (ROS) in tumor cells, while curcumin of high concentrations (80 μΜ) was able to significantly increase the content of ROS. In addition, Western blotting detection suggested that curcumin of high concentrations can induce the release of Cyto-C and the activation of Caspase-3, and that ROS scavenger NAC apparently inhibits apoptosis protein release and activation, consequently slowing the curcumin-induced apoptosis. Taken together, curcumin further activates the mitochondrial apoptotic pathway by inducing cells to generate ROS and ultimately promotes the apoptosis of tumor cells.
authors: Zhengqi
authors: Z
authors: Chang
authors: Junchao
authors: J
authors: Xing
authors: Xiuchun
authors: X
authors: Yu
mesh_terms: D017209:Apoptosis / Q000187:drug effects*; D001859:Bone Neoplasms / Q000378:metabolism*; D053148:Caspase 3 / Q000378:metabolism*; D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000187:drug effects; D003474:Curcumin / Q000494:pharmacology*; D045304:Cytochromes c / Q000378:metabolism*; D006801:Humans; D012516:Osteosarcoma / Q000378:metabolism*; D017382:Reactive Oxygen Species / Q000378:metabolism*; D015398:Signal Transduction / Q000187:drug effects*
chemical_list: D017382:Reactive Oxygen Species; D045304:Cytochromes c; D053148:Caspase 3; D003474:Curcumin
references: Ai Zheng. 2002 Dec;21(12):1296-300
references: 12520734
references: Fertil Steril. 2009 May;91(5 Suppl):2177-84
references: 18555241
references: FEBS Lett. 2002 Feb 13;512(1-3):334-40
references: 11852106
references: Int J Oncol. 2002 Aug;21(2):379-83
references: 12118335
references: Mol Pharmacol. 2007 Jul;72(1):29-39
references: 17395690
references: Tumour Biol. 2013 Oct;34(5):3209-18
references: 23760980
references: Anticancer Res. 2001 Mar-Apr;21(2A):873-8
references: 11396178
references: Int J Cancer. 2004 Sep 1;111(3):381-7
references: 15221965
references: Mutat Res. 2002 Jun 27;518(1):71-84
references: 12063069
references: Cancer Lett. 1995 Aug 16;95(1-2):221-5
references: 7656234
references: Exp Cell Res. 2001 Dec 10;271(2):305-14
references: 11716543
references: Biochem Pharmacol. 2003 Feb 1;65(3):361-76
references: 12527329
references: Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2006 Aug;41(8):612-6
references: 17039805
references: Int J Cancer. 2006 Feb 1;118(3):765-72
references: 16106398
references: Carcinogenesis. 2002 Jan;23(1):143-50
references: 11756235